A new approach involves subconjunctival drug delivering implants and locally applied antiangiogenic substances, which still have to be tested in clinical studies.

• 结膜下埋植剂等新方法的出现以及局部应用抗血管药物等都将成为治疗的新选择，但仍需经过临床验证。